A Study to Evaluate PT-523 in Patients With Refractory Leukemia
Clinical trial NCT00129558 · WITHDRAWN
Trial details
- NCT number
- NCT00129558
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2011-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.